Add your Insight
Manuscript deadline
15 July 2021

Expert Opinion on Pharmacotherapy
Special Issue Editor(s)
David Grech,
Taylor & Francis
[email protected]
Stephen N Davis,
University of Maryland Medical Center, MD
Diabetic Pharmacotherapy
Submissions are welcome for our special issue on “Diabetic Pharmacotherapy” in 2021 with Professor Stephen N Davis as our guest editor. This special issue covers all aspects of pharmacotherapy for the treatment of all types of diabetes and associated conditions. It will also provide expert perspectives on different treatment strategies and individual drug evaluations looking at promising up-and-coming drug treatments. We hope this issue will be both impactful and beneficial to both clinicians and pharmacologists. This issue also welcomes high-quality original research focused on the pharmacotherapy for the treatment of all types of diabetes and associated conditions.
Looking to Publish your Research?
We aim to make publishing with Taylor & Francis a rewarding experience for all our authors. Please visit our Author Services website for more information and guidance, and do contact us if there is anything we can help with!
Submission Instructions
The journal publishes a range of article types, including Reviews, Perspectives, Editorials, Special Reports, Meta-Analyses and Original Research. The deadline for articles submitted to be included in the Special Issue are as follows:
Rapid Track: 1st July 2021
Fast Track: 15th July 2021
Taylor & Francis is committed to enabling sustainable open research initiatives that lead to more open scholarly communications. If you are interested in making your article for this special issue Open Access, you can learn more about our Open Access publishing options here: https://authorservices.taylorandfrancis.com/publishing-open-access/.
View the latest tweets from tandfmedicine
Read more
Read more
Read more
Read more